Tekmira Pharmaceuticals Corporation – Trademark Portfolio

Entity Type: 03

Tekmira Pharmaceuticals Corporation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. The owner is based in Burnaby.

250 - 8900 Glenlyon Parkway

Burnaby V5J5J8 , CA

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TEKMIRA
TEKMIRA
Cancelled 2006
APIGRADE
APIGRADE
Cancelled 2003
TEKMIRA
TEKMIRA
Cancelled 2003

Trademark Classifications

Tekmira Pharmaceuticals Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Tekmira Pharmaceuticals Corporation have?

Tekmira Pharmaceuticals Corporation has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Tekmira Pharmaceuticals Corporation file in?

Tekmira Pharmaceuticals Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Tekmira Pharmaceuticals Corporation's trademark registration success rate?

Tekmira Pharmaceuticals Corporation has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.